Huons to challenge to next-generation anticoagulant ‘Pradaxa’ for first time

Huons will challenge to development of Pradaxa generics for the first time among other domestic pharmaceutical companies.

According to the Ministry of Food and Drug Safety(MFDS), Huons acquired approval for a bioequivalence test to develop Pradaxa generics on the last 9^th. Huons is the only company which acquired approval for the bioequivalence test after the approval of Pradaxa.

Pradaxa is t...